Dexcom is right on the precipice of launching its new G7 continuous glucose monitor in the US, following its recent CE marking in Europe.
It has recently been showing off a range of data supporting the G7’s efficacy and continued to do so at this year’s International Conference on Advanced Technologies and Treatments for Diabetes, held in Barcelona, Spain
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?